ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,733Medicare Part D Prescriptions Filled, Including Refills

Rank: 605 out of 6645

$4.29M Total Retail Price of All Prescriptions

Rank: 10 out of 6645

279 Patients Receiving at Least One Drug in Part D
34%Patients 65 Years and Older
58% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 279 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

41% of this provider’s 279 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

0% of this provider’s 2,804 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

48% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$366 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

42 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
TRUVADA 574 53 1 135
NORVIR 477 83 2 133
ISENTRESS 423 53 3 173
HYDROCODONE-ACETAMINOPHEN 414 93 S3 4 5
ACYCLOVIR 355 52 5 206
PREZISTA 327 52 6 194
ATORVASTATIN CALCIUM 267 91 7 10
INTELENCE 233 27 8 305
REYATAZ 228 35 9 197
LISINOPRIL 201 80 10 3
EPZICOM 181 36 11 223
PRAVASTATIN SODIUM 169 36 12 20
ATRIPLA 163 38 13 254
ANDROGEL 161 51 S3 14 279
ZOLPIDEM TARTRATE 153 28 15 17
OMEPRAZOLE 145 34 16 6
EMTRIVA 140 25 10 17 508
GABAPENTIN 115 29 18 18
METOPROLOL TARTRATE 110 40 19 13
TRAZODONE HCL 104 22 20 60
METFORMIN HCL 101 57 21 7
AZITHROMYCIN 100 24 22 44
TESTOSTERONE CYPIONATE 98 20 S3 23 324
BUPROPION XL 97 20 24 225
VIREAD 97 24 24 259
SIMVASTATIN 93 60 26 1
LEVOTHYROXINE SODIUM 90 67 27 4
SULFAMETHOXAZOLE-TRIMETHOPRIM 89 15 28 134
LAMIVUDINE 89 12 28 443
METOPROLOL SUCCINATE 85 52 30 24
FLUCONAZOLE 83 11 31 298
OXYCODONE HCL 77 0 S2 32 162
HYDROCHLOROTHIAZIDE 77 52 32 9
VALACYCLOVIR 73 12 34 271
DRONABINOL 72 0 35 463
QUINAPRIL HCL 71 17 36 270
TAMSULOSIN HCL 68 18 37 22
ALPRAZOLAM 68 0 37 195
INVIRASE 68 12 10 37 616
TRICOR 65 13 40 138
LORAZEPAM 64 33 41 189
ZOLPIDEM TARTRATE ER 62 0 42 500
RANITIDINE HCL 62 23 42 51
NEXIUM 59 0 44 40
PROAIR HFA 58 0 45 32
OXYCONTIN 56 0 S2 46 236
TOPIRAMATE 55 0 47 255
KALETRA 55 0 47 360
IBUPROFEN 55 0 47 42
DAPSONE 55 0 47 571
CYCLOBENZAPRINE HCL 54 12 R 51 157
SPIRIVA 54 14 51 65
BUPROPION HCL SR 53 0 53 296
JANUMET 52 0 54 132
LAMIVUDINE-ZIDOVUDINE 52 13 54 577
VIRAMUNE XR 52 16 54 371
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 11, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.